Connect to other sites within the UBM Medica Network
Surveillance Yields Excellent Long-Term Outcomes in Stage I Testicular Cancer
Active surveillance is effective and yields good outcomes in patients with clinical stage I testicular cancer who underwent orchiectomy.
CNS and Brain Tumors
This slide show features pathology slides of astrocytomas, subependymomas, medulloblastomas, meningiomas, ependymomas, glioblastomas, and oligodendrogliomas.
Tarextumab Gets FDA Orphan Drug Designation for Lung, Pancreatic Cancer
The US Food and Drug Administration has granted orphan drug designation to tarextumab for the treatment of pancreatic cancer and small-cell lung cancer.
FDA Approves Ibrutinib for Waldenström Macroglobulinemia
The FDA has expanded the approved use of ibrutinib (Imbruvica) to include patients with Waldenström macroglobulinemia, a rare type of non-Hodgkin lymphoma.
Adoption of Hypofractionated Radiotherapy in Early-Stage Breast Cancer
The benefit of hypofractionated radiotherapy for women receiving breast-conserving therapy for early-stage breast cancer is becoming more apparent.
MRD Identifies Relapse Risk in Pediatric ALL Post-Transplant
In a recent study of pediatric ALL, minimal residual disease was able to predict patients who were at increased risk for relapse post-allogeneic stem cell transplantation.
Genetic Variant Affects Treatment Intolerance in Pediatric ALL
Using genome-wide association studies, researchers have identified a germline variant that is associated with intolerance to mercaptopurine in pediatric ALL.
MBI Boosts Cancer Detection in Patients With Dense Breasts
Adding molecular breast imaging to mammography resulted in a fourfold increase in invasive breast cancer detection rates in women with dense breasts.
Smokers Have Worse Prostate Cancer Outcomes
Prostate cancer patients who smoke may be more susceptible to complications from treatment, and have increased risk of side effects and disease recurrence.
Breast Cancer Patients Often Don't Know Details of Their Tumor
Many women with breast cancer do not understand the details of their tumor characteristics or how they relate to specific treatment options, according to a new study.
By clicking Accept, you agree to become a member of the UBM Medica Community.